MEN1-associated neoplasms generally display a more aggressive clinical phenotype (e.g., multifocal tumors), yet surveillance in this population remains insufficient as upward of 60% of MEN1-gastrinoma cases present with metastases upon diagnosis (7). Here, MEN1 is linked to gastrin-producing neuroendocrine tumor.